Advisory panel recommends “signal monitoring” to anticipate potential risks
Although it lacks a supply-chain focused work group, the International Soc. For Pharmaceutical Engineering (ISPE; Tampa, FL) has published a white paper on supply chain security for both ingredients and finished products. The report is available, free, at ISPE’s website, ispe.org.
ISPE used what it calls its International Leadership Forum to author the report, Supply Chain Security: A Comprehensive and Practical Approach.” For the most part, the paper provides sensible, simple procedures to evaluate and audit the performance of materials suppliers, logistics providers and manufacturers’ own internal practices. Some parts are fairly tedious (recommending, for example, that quality inspectors check both the left and the right sides of shipping containers), but also present some valuable new thinking. One example of that is a recommendation to monitor supply disruptions such as plant shutdowns or unseasonable weather—situations that could lead to material shortages and price hikes—as opportunities for bad actors to begin marketing adulterated or fake products.
The report skips over the existence of pedigree programs—important, in some states, as a means of product authentication. Among the “opportunities for deterrence” it mentions is use of security features (overt, covert, forensic, tamper-evidence, and serialization/track and trace). It also recommends carefully evaluating the practices of the “customer,” defined as the first point where legal ownership of product changes—but says next to nothing about second- or third transaction points. It also highlights the need for theft prevention in storage facilities or cargo transport.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.